LifeStance Health (LFST) Cash from Investing Activities (2020 - 2026)

LifeStance Health has disclosed Cash from Investing Activities across 7 years of filings, most recently posting -$13.9 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 94.07% year-over-year to -$13.9 million; the TTM figure through Mar 2026 stood at -$42.9 million (down 81.41% YoY), while the FY2025 annual figure was -$36.1 million, down 67.51% from the prior year.
• Cash from Investing Activities declined to -$13.9 million in Q1 2026, from -$10.9 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for LFST reached as high as -$5.1 million in Q3 2024 and fell as low as -$50.9 million in Q1 2022.
• The 5-year median for Cash from Investing Activities is -$10.9 million (2025), against an average of -$16.0 million.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities plunged 329.7% — and 2024, when it jumped 81.47%.
• A 5-year view of Cash from Investing Activities shows it stood at -$30.3 million in 2022, then jumped by 62.33% to -$11.4 million in 2023, then soared by 44.8% to -$6.3 million in 2024, then tumbled by 73.16% to -$10.9 million in 2025, then dropped by 27.5% to -$13.9 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$13.9 million, -$10.9 million, and -$10.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.